PL2575847T5 - Sposoby oczyszczania polipeptydów - Google Patents

Sposoby oczyszczania polipeptydów

Info

Publication number
PL2575847T5
PL2575847T5 PL11787363.8T PL11787363T PL2575847T5 PL 2575847 T5 PL2575847 T5 PL 2575847T5 PL 11787363 T PL11787363 T PL 11787363T PL 2575847 T5 PL2575847 T5 PL 2575847T5
Authority
PL
Poland
Prior art keywords
methods
purifying polypeptides
polypeptides
purifying
Prior art date
Application number
PL11787363.8T
Other languages
English (en)
Other versions
PL2575847T3 (pl
Inventor
Hui F. Liu
Brian David Kelley
Deanna E. Myers
Beth Mccooey
Krista Marie Petty
Original Assignee
F.Hoffmann-La Roche Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=45004368&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2575847(T5) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by F.Hoffmann-La Roche Ag filed Critical F.Hoffmann-La Roche Ag
Publication of PL2575847T3 publication Critical patent/PL2575847T3/pl
Publication of PL2575847T5 publication Critical patent/PL2575847T5/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/18—Ion-exchange chromatography
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction
    • B01D15/361—Ion-exchange
    • B01D15/362—Cation-exchange
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 - B01D15/36
    • B01D15/3847—Multimodal interactions
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/165—Extraction; Separation; Purification by chromatography mixed-mode chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
    • G01N2030/8809—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample
    • G01N2030/8813—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials
    • G01N2030/8831—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials involving peptides or proteins
PL11787363.8T 2010-05-25 2011-05-25 Sposoby oczyszczania polipeptydów PL2575847T5 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US34814310P 2010-05-25 2010-05-25
PCT/US2011/037977 WO2011150110A1 (en) 2010-05-25 2011-05-25 Methods of purifying polypeptides
EP11787363.8A EP2575847B2 (en) 2010-05-25 2011-05-25 Methods of purifying polypeptides

Publications (2)

Publication Number Publication Date
PL2575847T3 PL2575847T3 (pl) 2017-10-31
PL2575847T5 true PL2575847T5 (pl) 2022-07-18

Family

ID=45004368

Family Applications (1)

Application Number Title Priority Date Filing Date
PL11787363.8T PL2575847T5 (pl) 2010-05-25 2011-05-25 Sposoby oczyszczania polipeptydów

Country Status (21)

Country Link
US (4) US20130079272A1 (pl)
EP (2) EP2575847B2 (pl)
JP (3) JP5934190B2 (pl)
KR (1) KR101976853B1 (pl)
CN (2) CN107365346A (pl)
AU (1) AU2011258254B2 (pl)
BR (1) BR112012029904A2 (pl)
CA (2) CA2799915C (pl)
ES (1) ES2637613T5 (pl)
HK (1) HK1246328A1 (pl)
HR (1) HRP20171095T4 (pl)
IL (2) IL223029A0 (pl)
MX (2) MX370828B (pl)
MY (1) MY161534A (pl)
NZ (1) NZ603648A (pl)
PL (1) PL2575847T5 (pl)
RU (1) RU2594163C2 (pl)
SG (2) SG10201710439UA (pl)
SI (1) SI2575847T2 (pl)
WO (1) WO2011150110A1 (pl)
ZA (1) ZA201208673B (pl)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10047144B2 (en) * 2011-10-19 2018-08-14 Novimmune Sa Methods of purifying antibodies
SI2794635T1 (sl) 2011-12-22 2018-12-31 F. Hoffmann-La Roche Ag Ionskoizmenjevalna membranska kromatografija
CN102911250B (zh) * 2012-09-29 2014-04-16 浙江海正药业股份有限公司 酸性重组蛋白药物的纯化方法
CN103880947B (zh) * 2012-12-21 2016-01-13 武汉禾元生物科技股份有限公司 一种分离纯化高纯度重组人血清白蛋白的层析方法
WO2014118685A2 (en) * 2013-01-29 2014-08-07 Dr. Reddy's Laboratories Limited Method of altering the acidic variant content of antibody
EP2971087B1 (en) 2013-03-14 2017-11-01 Qiagen Sciences, LLC Assessing dna quality using real-time pcr and ct values
CN104236983A (zh) * 2013-06-14 2014-12-24 中国科学院大连化学物理研究所 溶液样品中含长烷基链的离子液体的去除方法
EP3041593A4 (en) * 2013-09-05 2017-08-30 F. Hoffmann-La Roche AG Method for chromatography reuse
CA3174012A1 (en) 2013-09-13 2015-03-19 Genentech, Inc. Compositions and methods for detecting and quantifying host cell protein in cell lines and recombinant polypeptide products
KR102571391B1 (ko) 2013-09-13 2023-08-29 제넨테크, 인크. 정제된 재조합 폴리펩티드를 포함하는 방법 및 조성물
AU2014337263B2 (en) 2013-10-16 2019-12-12 Outlook Therapeutics, Inc. Buffer formulations for enhanced antibody stability
US8859252B1 (en) 2014-01-02 2014-10-14 Aerial Biopharma, Llc Prostatic acid phosphatase, compositions comprising the same, and methods for producing and/or purifying the same
WO2015105551A1 (en) 2014-01-09 2015-07-16 Kentucky Bioprocessing, Inc. Method of purifying monoclonal antibodies
LT3116891T (lt) 2014-03-10 2020-03-25 Richter Gedeon Nyrt. Imunoglobulino gryninimas, naudojant išankstinio valymo pakopas
JP6647220B2 (ja) * 2014-05-23 2020-02-14 インスティトゥート・マッソーネ・エセ・ア Ｈｍｇ−ｕｐ（超高純度グレードのヒト閉経期ゴナドトロピン）を得るための方法及び夾雑物を含まない組成物
EP3145951A1 (en) * 2014-06-24 2017-03-29 InSight Biopharmaceuticals Ltd. Methods of purifying antibodies
GB201411802D0 (en) 2014-07-02 2014-08-13 Univ Bradford Effervescent compositions
WO2016118707A1 (en) * 2015-01-21 2016-07-28 Oncobiologics, Inc. Modulation of charge variants in a monoclonal antibody composition
EP3411401A1 (en) 2016-02-03 2018-12-12 Oncobiologics, Inc. Buffer formulations for enhanced antibody stability
WO2017218977A2 (en) 2016-06-17 2017-12-21 Genentech, Inc. Purification of multispecific antibodies
EP3497440A1 (en) * 2016-08-15 2019-06-19 H. Hoffnabb-La Roche Ag Chromatography method for quantifying a non-ionic surfactant in a composition comprising the non-ionic surfactant and a polypeptide
JP6564539B1 (ja) 2018-09-14 2019-08-21 長瀬産業株式会社 スルホン酸化合物によるペプチド精製方法
JP7458404B2 (ja) 2018-12-20 2024-03-29 アーマジェン・インコーポレイテッド イズロン酸－２－スルファターゼ免疫グロブリン融合タンパク質の精製
CN109765307B (zh) * 2018-12-24 2021-06-29 山东省科学院海洋仪器仪表研究所 一种水体中六氯环己烷的测量方法
CN111366547A (zh) * 2018-12-26 2020-07-03 贵州中烟工业有限责任公司 一种用连续流动法测定烟草或烟草制品中α-氨基氮的检测方法
TW202045527A (zh) 2019-01-23 2020-12-16 日商第一三共股份有限公司 包含使用活性碳材料之步驟之抗體純化方法
TW202112799A (zh) * 2019-06-05 2021-04-01 美商建南德克公司 過載層析管柱之再生方法
WO2021076489A1 (en) * 2019-10-14 2021-04-22 Pierce Biotechnology, Inc. Peptide purification formulations and methods
WO2022015934A2 (en) * 2020-07-15 2022-01-20 The Johns Hopkins Universtiy Comprehensive analysis of anti-allergen antibodies using phage display
CN112852876B (zh) * 2021-03-04 2022-11-29 西南大学 一种表达人表皮生长因子的家蚕丝腺重组表达载体及其制备方法和应用
TW202304946A (zh) 2021-03-31 2023-02-01 瑞士商赫孚孟拉羅股份公司 藉由混合模式層析純化抗體

Family Cites Families (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4704362A (en) 1977-11-08 1987-11-03 Genentech, Inc. Recombinant cloning vehicle microbial polypeptide expression
FR2413974A1 (fr) 1978-01-06 1979-08-03 David Bernard Sechoir pour feuilles imprimees par serigraphie
US4399216A (en) 1980-02-25 1983-08-16 The Trustees Of Columbia University Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
US4419446A (en) 1980-12-31 1983-12-06 The United States Of America As Represented By The Department Of Health And Human Services Recombinant DNA process utilizing a papilloma virus DNA as a vector
NZ201705A (en) 1981-08-31 1986-03-14 Genentech Inc Recombinant dna method for production of hepatitis b surface antigen in yeast
US4601978A (en) 1982-11-24 1986-07-22 The Regents Of The University Of California Mammalian metallothionein promoter system
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4965199A (en) 1984-04-20 1990-10-23 Genentech, Inc. Preparation of functional human factor VIII in mammalian cells using methotrexate based selection
US4676980A (en) 1985-09-23 1987-06-30 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Target specific cross-linked heteroantibodies
US5567610A (en) 1986-09-04 1996-10-22 Bioinvent International Ab Method of producing human monoclonal antibodies and kit therefor
IL85035A0 (en) 1987-01-08 1988-06-30 Int Genetic Eng Polynucleotide molecule,a chimeric antibody with specificity for human b cell surface antigen,a process for the preparation and methods utilizing the same
US5169770A (en) 1987-12-21 1992-12-08 The University Of Toledo Agrobacterium mediated transformation of germinating plant seeds
GB8823869D0 (en) 1988-10-12 1988-11-16 Medical Res Council Production of antibodies
US5175384A (en) 1988-12-05 1992-12-29 Genpharm International Transgenic mice depleted in mature t-cells and methods for making transgenic mice
FR2646437B1 (fr) 1989-04-28 1991-08-30 Transgene Sa Nouvelles sequences d'adn, leur application en tant que sequence codant pour un peptide signal pour la secretion de proteines matures par des levures recombinantes, cassettes d'expression, levures transformees et procede de preparation de proteines correspondant
EP0402226A1 (en) 1989-06-06 1990-12-12 Institut National De La Recherche Agronomique Transformation vectors for yeast yarrowia
DE3920358A1 (de) 1989-06-22 1991-01-17 Behringwerke Ag Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung
ES2096590T3 (es) 1989-06-29 1997-03-16 Medarex Inc Reactivos biespecificos para la terapia del sida.
US5208020A (en) 1989-10-25 1993-05-04 Immunogen Inc. Cytotoxic agents comprising maytansinoids and their therapeutic use
US5229275A (en) 1990-04-26 1993-07-20 Akzo N.V. In-vitro method for producing antigen-specific human monoclonal antibodies
US5571894A (en) 1991-02-05 1996-11-05 Ciba-Geigy Corporation Recombinant antibodies specific for a growth factor receptor
WO1992020373A1 (en) 1991-05-14 1992-11-26 Repligen Corporation Heteroconjugate antibodies for treatment of hiv infection
JP4124480B2 (ja) 1991-06-14 2008-07-23 ジェネンテック・インコーポレーテッド 免疫グロブリン変異体
IE922437A1 (en) 1991-07-25 1993-01-27 Idec Pharma Corp Recombinant antibodies for human therapy
ES2136092T3 (es) 1991-09-23 1999-11-16 Medical Res Council Procedimientos para la produccion de anticuerpos humanizados.
US5587458A (en) 1991-10-07 1996-12-24 Aronex Pharmaceuticals, Inc. Anti-erbB-2 antibodies, combinations thereof, and therapeutic and diagnostic uses thereof
WO1993008829A1 (en) 1991-11-04 1993-05-13 The Regents Of The University Of California Compositions that mediate killing of hiv-infected cells
EP0617706B1 (en) 1991-11-25 2001-10-17 Enzon, Inc. Multivalent antigen-binding proteins
WO1993016185A2 (en) 1992-02-06 1993-08-19 Creative Biomolecules, Inc. Biosynthetic binding protein for cancer marker
EP0626012B1 (en) 1992-02-11 2003-07-09 Cell Genesys, Inc. Homogenotization of gene-targeting events
US5573905A (en) 1992-03-30 1996-11-12 The Scripps Research Institute Encoded combinatorial chemical libraries
EP0656064B1 (en) 1992-08-17 1997-03-05 Genentech, Inc. Bispecific immunoadhesins
US5736137A (en) 1992-11-13 1998-04-07 Idec Pharmaceuticals Corporation Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
RO118524B1 (ro) 1992-11-13 2003-06-30 Idec Pharmaceuticals Corp San Metoda pentru tratarea unei tulburari legata de celulele b
CA2106612C (en) * 1993-09-21 2001-02-06 Diana Pliura Displacement chromatography process
US5545328A (en) * 1993-09-21 1996-08-13 Hemosol Inc. Purification of hemoglobin by displacement chromatography
US5534615A (en) 1994-04-25 1996-07-09 Genentech, Inc. Cardiac hypertrophy factor and uses therefor
US5840523A (en) 1995-03-01 1998-11-24 Genetech, Inc. Methods and compositions for secretion of heterologous polypeptides
US5731168A (en) 1995-03-01 1998-03-24 Genentech, Inc. Method for making heteromultimeric polypeptides
US5641870A (en) 1995-04-20 1997-06-24 Genentech, Inc. Low pH hydrophobic interaction chromatography for antibody purification
US5712374A (en) 1995-06-07 1998-01-27 American Cyanamid Company Method for the preparation of substantiallly monomeric calicheamicin derivative/carrier conjugates
WO1997027757A1 (en) * 1996-01-31 1997-08-07 John Stephen Ayers Production of an immunoglobulin enriched fraction from whey protein solutions
US6037454A (en) 1996-11-27 2000-03-14 Genentech, Inc. Humanized anti-CD11a antibodies
US20020032315A1 (en) 1997-08-06 2002-03-14 Manuel Baca Anti-vegf antibodies
EP1075488B2 (en) * 1998-05-06 2013-08-07 Genentech, Inc. Protein purification by ion exchange chromatography
SE526227C2 (sv) * 2002-05-15 2005-08-02 North China Pharmaceutical Group Metod för rening av rekombinant humant serumalbumin
AU2005285347A1 (en) 2004-08-19 2006-03-23 Genentech, Inc. Polypeptide variants with altered effector function
RU2412947C2 (ru) 2004-09-23 2011-02-27 Дженентек, Инк. Антитела, сконструированные на основе цистеинов, и их конъюгаты
AU2005296352B2 (en) † 2004-10-21 2011-01-06 Cytiva Bioprocess R&D Ab Chromatography ligand
US8067182B2 (en) * 2005-03-11 2011-11-29 Wyeth Llc Method of weak partitioning chromatography
US8129508B2 (en) * 2005-04-11 2012-03-06 Medarex, Inc. Protein purification using HCIC and ion exchange chromatography
US7691980B2 (en) * 2007-01-09 2010-04-06 Bio-Rad Laboratories, Inc. Enhanced capacity and purification of antibodies by mixed mode chromatography in the presence of aqueous-soluble nonionic organic polymers
US9433922B2 (en) * 2007-08-14 2016-09-06 Emd Millipore Corporation Media for membrane ion exchange chromatography based on polymeric primary amines, sorption device containing that media, and chromatography scheme and purification method using the same
RU2498991C2 (ru) † 2007-10-30 2013-11-20 Дженентек, Инк. Очистка антител с помощью катионообменной хроматографии
US8188242B2 (en) † 2008-04-08 2012-05-29 Bio-Rad Laboratories, Inc. Chromatography purification of antibodies
KR101843915B1 (ko) † 2008-08-14 2018-04-02 제넨테크, 인크. 고유 단백질 대체 이온 교환 막 크로마토그래피를 이용한 오염물의 제거 방법
US8497358B2 (en) 2008-12-19 2013-07-30 Takeda Pharmaceutical Company Limited Antibody purification method
AU2010221099A1 (en) * 2009-03-06 2011-09-22 Medimmune, Llc Humanized anti-CD19 antibody formulations
WO2011037983A1 (en) * 2009-09-23 2011-03-31 Medarex, Inc. Cation exchange chromatography

Also Published As

Publication number Publication date
US20190300566A1 (en) 2019-10-03
EP2575847B1 (en) 2017-06-14
JP2016190851A (ja) 2016-11-10
PL2575847T3 (pl) 2017-10-31
US20200399307A1 (en) 2020-12-24
CA2799915C (en) 2023-09-26
EP2575847B2 (en) 2022-04-27
AU2011258254B2 (en) 2016-01-07
US20220064209A1 (en) 2022-03-03
BR112012029904A2 (pt) 2017-08-08
IL261147A (en) 2018-10-31
SI2575847T2 (sl) 2022-08-31
HRP20171095T4 (hr) 2022-07-22
ZA201208673B (en) 2016-02-24
HRP20171095T1 (hr) 2017-10-06
MX344248B (es) 2016-12-09
KR20130086544A (ko) 2013-08-02
HK1246328A1 (zh) 2018-09-07
CA3209878A1 (en) 2011-12-01
US20130079272A1 (en) 2013-03-28
CN102905718A (zh) 2013-01-30
RU2012156271A (ru) 2014-06-27
SI2575847T1 (sl) 2017-09-29
EP2575847A1 (en) 2013-04-10
MY161534A (en) 2017-04-28
CN107365346A (zh) 2017-11-21
AU2011258254A1 (en) 2013-01-10
CA2799915A1 (en) 2011-12-01
IL223029A0 (en) 2013-02-03
JP2018087192A (ja) 2018-06-07
EP3299380A1 (en) 2018-03-28
EP2575847A4 (en) 2014-10-08
KR101976853B1 (ko) 2019-05-09
JP6272941B2 (ja) 2018-01-31
ES2637613T3 (es) 2017-10-13
NZ603648A (en) 2014-12-24
JP5934190B2 (ja) 2016-06-15
MX2012013575A (es) 2013-03-21
SG10201710439UA (en) 2018-01-30
SG185737A1 (en) 2013-01-30
JP2013530156A (ja) 2013-07-25
WO2011150110A1 (en) 2011-12-01
RU2594163C2 (ru) 2016-08-10
MX370828B (es) 2020-01-08
ES2637613T5 (es) 2022-07-20

Similar Documents

Publication Publication Date Title
IL261147A (en) Methods for purification of polypeptides
HK1246330A1 (zh) 蛋白質純化
IL225650A0 (en) Protein purification processes
EP3715356C0 (en) PROCESS FOR PURIFYING POLYPEPTIDES
HK1182719A1 (en) Polypeptides
PT2539136T (pt) Poste de barreira e método de fabrico do mesmo
GB201004638D0 (en) Separation of gases
IL222900A (en) Forms of Rifaximin
SI2598516T1 (sl) Postopek za čiščenje proteinov
GB201107987D0 (en) Bridge
SG10201501080VA (en) Method For The Determination Of Sequence Variants Of Polypeptides
EP2619333A4 (en) PARALLEL SEQUENCING WITH NATIVE EXTENSION
HK1162953A1 (en) Novel use of hesperetin
HK1160777A1 (en) Novel use of neohesperidoside
GB201012110D0 (en) Separation of gases
GB201001710D0 (en) Separation of gases
GB201001193D0 (en) Separation of gases
HU1000688D0 (en) Use of trifluoro-phal
TWM390349U (en) Structure of door-in-door
TWM386865U (en) Residue-filtering structure of juice-extractor
GB201004059D0 (en) Method of construction
TWM400763U (en) Improved structure of cold-accumulating cravats
TWM388315U (en) Improved structure of hemoclip
TWM390745U (en) Structure improvement of tea-making can